D
Daymark Health
Clariture | Enterprise Healthcare Marketing™
About Daymark Health
Daymark Health operates as a value-based oncology care company, aiming to address fragmentation in the cancer treatment landscape. The company was co-founded by CEO Dr. Justin Bekelman, an oncologist who previously led Penn Medicine's Center for Cancer Care Innovation, alongside Robert Pahlavan and Jonathan Rhodes from the venture studio Healthcare Foundry. Dr. Bekelman's two-decade career in oncology, which includes authoring nearly 200 research articles and advising on cancer care payment reform, directly informs the company's patient-centric model. Daymark emerged from Healthcare Foundry, a venture studio that builds healthcare companies, where Pahlavan and Rhodes led the initial thesis development before taking operational roles at the new company.
The firm's business model is centered on establishing partnerships with health plans, for which it takes on total cost of care risk contracts. Through these partnerships, Daymark provides supplementary supportive care to cancer patients, working in tandem with their existing oncologists and primary care providers. This service is delivered through a hybrid model that combines in-home visits from a clinical team and virtual support. The target market is the approximately two million people diagnosed with cancer annually in the U.S. who spend the vast majority of their time outside a clinical setting.
Daymark's platform provides a suite of wraparound services designed to manage the comprehensive needs of patients. This includes dedicated care navigation, 24/7 support, symptom management, behavioral and mental health assistance, and social support. A key component is early palliative care and a user-friendly symptom management platform that patients interact with twice a week. The company deploys a community-based team of nurse practitioners, nurses, social workers, and 'Health Partners' to deliver this care. In early 2025, the Philadelphia-based company launched publicly with $11.5 million in seed funding co-led by Maverick Ventures and Yosemite, with participation from Oncology Ventures. At launch, Daymark had already initiated operations with a payer in the Northeast, serving over 2,500 cancer patients.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2025 | $20M | $80M | Undisclosed | ↗ |
| SEED✓Equity / VC | Apr 2025 | $12M | $46M | Oncology Ventures · Maverick Ventures · Yosemite | ↗ |
Growth signals
Latest recorded traffic for Daymark Health is 780 monthly website visits, down 70% over the last three months. Daymark Health's team grew 183.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Daymark Health in the Nashville ecosystem
The Daymark Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Maverick Ventures
Yosemite
Oncology Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Daymark Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Daymark Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










